Indian Diagnostic Company Transasia Bio-Medical Acquires Pliva Lachema Diagnostica

An Indian clinical diagnostics company, Transasia Bio-Medicals Ltd. (Mumbai, India) has acquired Pliva Lachema Diagnostika (Brno, Czech Republic). The acquisition will bring advanced technology within reach for India's vast population.

The acquisition provides an opportunity for Transasia and ERBA to introduce newer products to the swiftly developing markets of Asia. Transasia and its 100% German subsidiary, ERBA Diagnostics Mannheim GmbH (Germany) have a team of experienced marketing and service professionals and a large distribution network. It markets products in countries, which include Italy, Germany, France, China, Turkey, Russia, and around the globe.

PLIVA Lachema Diagnostika develops, produces, and markets in vitro diagnostics (IVD) products for urine analysis, biochemistry, and microbiology. The company has an extensive marketing and distribution network in the countries of Central and Eastern Europe, which will complement the current market potential and product lines of Transasia and ERBA Mannheim

Lachema's customers in Central and Eastern Europe will have access to Transasia's large product range in clinical chemistry, immunoturbidimetry, and immunology. Transasia Bio-Medicals Ltd. and ERBA Diagnostics Mannheim intend to invest more than US$1 million in Lachema to increase its manufacturing capacities and add new quality, affordable, wide spectrum products in the near future.

Related Links:
Transasia Bio-Medicals Ltd.
Pliva Lachema Diagnostika